Aura Biosciences

Aura Biosciences
Last activity: 12.03.2024
Categories: LifeITGrowthTechnologyProductDevelopmentAppAlternativeFastDrug
Aura Biosciences is pioneering a first-in-class technology to treat a wide variety of solid tumor types. We are initially pursuing cancers where patients are in need of a transformational change in treatment options, such as choroidal melanoma, so they can avoid choosing between preserving their life or their vision
Website visits
5.5K /mo.
Location: United States, Massachusetts, Cambridge
Employees: 51-200
Total raised: $183M
Founded date: 2009

Investors 8

Funding Rounds 6

02.04.2019Series D$40M-
21.12.2017Series C$30MArix Biosc...
05.03.2015Series B$21M-

Mentions in press and media 34

12.03.2024Clearside Biomedical Announces Fourth Quarter and Full Year ...- Phase 2b ODYSSEY Wet AMD Trial Remains on Track with Topline Data Expected in Q3 2024 - - Partner ...einpresswi...
03.05.2023WCVB Channel 5 Chronicle Reporter and Producer Nicole Estaph...BOSTON (PRWEB) May 03, 2023 The Melanoma Research Foundation (MRF) is thrilled to announce that
22.11.2022Aura, the frame and photo startup, raises $26M as it nears 3...Aura, a startup founded by early Twitter employees that makes digital frames and photo sharing apps ...techcrunch...
07.11.2022Prevent Blindness Names Jim McGrann Chair of its Board of Di...Jim McGrann, CEO of Professional Eyecare Associates of America (PECAA), named Chair of the Prevent
03.11.2021Ysios Capital’s portfolio company Aura Biosciences prices IP...03/11/2021 Press release YSIOS CAPITAL’S PORTFOLIO COMPANY AURA BIOSCIENCES PRICES IPO ON NASDAQ. ...webcapital...
03.11.2021Ysios Capital anuncia la salida a bolsa en el NASDAQ de su c...03/11/2021 Nota de prensa YSIOS CAPITAL ANUNCIA LA SALIDA A BOLSA EN EL NASDAQ DE SU COMPAÑÍA PART...webcapital...
23.03.2021Aura Biosciences picks up $80MAura Biosciences has raised $80 million in a round co-led by Matrix Capital Management and Surveyor ...pitchbook....
22.03.2021Aura Biosciences Announces Oversubscribed $80 Million Financ...CAMBRIDGE, Mass.--(BUSINESS WIRE)--Mar 22, 2021-- Aura Biosciences, a clinical-stage oncology
22.03.2021Aura Biosciences cierra una ronda de $80M liderada por Matri...22/03/2021 Nota de prensa YSIOS CAPITAL PARTICIPA EN LA RONDA DE FINANCIACIÓN DE $80 MILLONES DE S...webcapital...
22.03.2021Aura Biosciences announces oversubscribed $80 million financ...22/03/2021 Press release AURA BIOSCIENCES ANNOUNCES OVERSUBSCRIBED $80M FINANCING. Proceeds to Su...webcapital...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In